business
COMPANY BENCHMARKING • UNITED STATES

Gilead Sciences, Inc. - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Gilead Sciences, Inc. stacks up to the competition and put relevant competitor and industry information at your fingertips.


Gilead Sciences, Inc. - Overview

Description
Gilead Sciences is a public company headquartered in California with an estimated 13,600 employees. In the US, the company has a notable market share in at least one industry: Biotechnology, where they account for an estimated 4.6% of total industry revenue.
Company Details

Registered Name: Gilead Sciences, Inc.

Company Type: Operating

Exchange: Nasdaq

Headquarters: 333 Lakeside Dr Foster City CA 94404

Website: https://www.gilead.com/

Employees: 13600

Gilead Sciences, Inc. - Operating Industries and Main Competitors

error_outline To view all of Gilead Sciences, Inc.'s operating industries and competitors, see purchase options.

Gilead Sciences, Inc. - Products and Services

  • Biotechnology in the US

    • Of the 5 core revenue-generating products and services in the Biotechnology in the US industry, Gilead Sciences, Inc. offers:
    • Human health technologies
error_outline To view Gilead Sciences, Inc.'s full products and services, see purchase options.

Gilead Sciences, Inc. - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on Gilead Sciences, Inc.'s performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Biotechnology in the US industry.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view Gilead Sciences, Inc.'s full SWOT analysis, see purchase options.

Gilead Sciences, Inc. - Financial Statements & Ratios

pie_chartGilead Sciences, Inc. Income Statement

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/201712/31/2016
Revenue27,305.024,689.022,449.022,127.026,107.030,390.0
Cost of Revenue000000000000000000000000
Cost of Revenue, Non-Cash000000000000000000000000
Gross Profit000000000000000000000000
AAAAAA AAAAAA000000000000000000000000

pie_chartGilead Sciences, Inc. Balance Sheet

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/201712/31/2016
Cash and Equivalents5,338.05,997.011,631.017,940.07,588.08,229.0
Short-Term Investments000000000000000000000000
Derivative Assets, Current000000000000000000000000
Restricted Cash and Investments000000000000000000000000
AAAAAA AAAAAA000000000000000000000000

pie_chartGilead Sciences, Inc. Cash Flow

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/201712/31/2016
Net Income6,201.089.05,364.05,460.04,644.013,488.0
Income (Loss) From Discontinued Operations000000000000000000000000
Depreciation, Depletion and Amortization000000000000000000000000
Amortization of Financing Costs and Discounts000000000000000000000000
AAAAAA AAAAAA000000000000000000000000

error_outline To view all financial data for Gilead Sciences, Inc., see purchase options.

GET INSTANT ACCESS WITH BENCHMARKING PRO MEMBERSHIP

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

A suite of company and industry data that:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy
LEARN MORE

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on Gilead Sciences, Inc. includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

  • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal